CEREBRAL INFARCTION
Clinical trials for CEREBRAL INFARCTION explained in plain language.
Never miss a new study
Get alerted when new CEREBRAL INFARCTION trials appear
Sign up with your email to follow new studies for CEREBRAL INFARCTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to protect brain after stroke clot removal
Disease control Not yet recruitingThis early-stage study tests the safety of a drug called EMPAVELI in 20 adults who had a stroke from a large blood clot and already had it removed. The drug is given through a pump shortly after the procedure and again at 24 and 48 hours to reduce swelling and inflammation when b…
Matched conditions: CEREBRAL INFARCTION
Phase: PHASE1 • Sponsor: Columbia University • Aim: Disease control
Last updated May 17, 2026 06:09 UTC
-
New hope for late-arriving stroke patients: MRI-guided drug shows promise
Disease control Not yet recruitingThis study tests whether the drug tirofiban can help people who had a stroke more than 24 hours ago but within 7 days. It uses a special MRI scan to pick the right patients. About 458 adults will take part to see if the drug improves recovery without causing serious bleeding.
Matched conditions: CEREBRAL INFARCTION
Phase: PHASE3 • Sponsor: Weifang Medical University • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Could earlier aspirin after stroke save more brain function?
Disease control Not yet recruitingThis study looks at whether giving a low-dose aspirin just 2 hours after clot-busting treatment for stroke is safer and more effective than waiting the usual 24 hours. About 210 adults aged 18-65 with acute ischemic stroke will be randomly assigned to one of two timing schedules.…
Matched conditions: CEREBRAL INFARCTION
Phase: PHASE4 • Sponsor: Beijing Chao Yang Hospital • Aim: Disease control
Last updated May 12, 2026 13:43 UTC